Skip to content
website_landing_page_desktop_banner (1)-Apr-27-2026-05-06-49-4035-PM
website_landing_page_mobile_banner-Apr-27-2026-05-06-32-1678-PM

Meet the Cloudbyz AI RegCheck Agent: The AI Co-Pilot for Regulatory Affairs

Thursday, May 28, 2026 · 11 AM – 12 PM EST

The path to FDA approval is stalled by manual oversight and fragmented documentation. The AI RegCheck Agent automates the grueling task of document-to-regulation mapping. By combining real-time regulatory intelligence with a "human-in-the-loop" interface, we help regulatory teams catch critical gaps weeks before the filing deadline.

Key Benefits

  • Live Regulatory Alignment: Unlike static templates, our AI pulls from live FDA databases to ensure your checklist reflects current guidance.

  • Instant Source Traceability: Every finding includes a direct link to the specific page and paragraph in your source files. No "black box" logic.

  • Audit-Ready Workflows: Every AI suggestion is reviewable and overridable. All changes are logged for a complete audit trail.

  • Holistic Package Review: Scan your entire submission folder simultaneously to identify inconsistencies across clinical and technical modules.

What You’ll See in the Demo

  • Automated Checklist Generation: Building a submission-specific requirements list in minutes.

  • The Gap Analysis Engine: Uploading document sets and receiving a prioritized list of missing or non-compliant elements.

  • Evidence Mapping: A walkthrough of the "Click-to-Source" feature for rapid verification.

  • Human Oversight Interface: How RA professionals validate or dismiss AI findings to maintain control.

Key Takeaways

  • How to shift from manual document checking to strategic regulatory review.

  • Methods for identifying "hidden" gaps that lead to Refuse-to-Accept (RTA) decisions.

  • Techniques for maintaining 100% data integrity in AI-assisted workflows.


Thank you for attending our live webinar! The on-demand video is currently in production and will be available soon.

Register for the Webinar